Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
LLYVA Quote, Financials, Valuation and Earnings
Last price:
$80.65
Seasonality move
:
31.69%
Day range:
$79.36 - $80.98
52-week range:
$34.56 - $81.85
Dividend yield:
0%
P/E ratio:
294.82x
P/S ratio:
--
P/B ratio:
--
Volume:
146.8K
Avg. volume:
77.5K
1-year change:
112.06%
Market cap:
$7.4B
Revenue:
--
EPS (TTM):
$0.27
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $11M | $11M | |
| Other Inc / (Exp) | -- | -- | -- | -$159M | -$1M | |
| Operating Expenses | -- | -- | -- | $11M | $11M | |
| Operating Income | -- | -- | -- | -$11M | -$11M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$180M | -$41M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$38M | -$8M | |
| Net Income to Company | -- | -- | -- | -$142M | -$33M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $2M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$142M | -$31M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$1.55 | -$0.34 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$1.55 | -$0.34 | |
| Weighted Average Basic Share | -- | -- | -- | $91.7M | $91.8M | |
| Weighted Average Diluted Share | -- | -- | -- | $91.7M | $91.8M | |
| EBITDA | -- | -- | -- | -$170M | -$12M | |
| EBIT | -- | -- | -- | -$170M | -$12M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -$11M | -$11M | |
| Operating Income (Adjusted) | -- | -- | -- | -$170M | -$12M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $2M | $4M | |
| Other Inc / (Exp) | -- | -- | -- | -$84M | -$11M | |
| Operating Expenses | -- | -- | -- | $2M | $4M | |
| Operating Income | -- | -- | -- | -$2M | -$4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$93M | -$22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$20M | -$5M | |
| Net Income to Company | -- | -- | -- | -$73M | $77M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$73M | -$17M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.80 | -$0.19 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.80 | -$0.19 | |
| Weighted Average Basic Share | -- | -- | -- | $91.7M | $91.8M | |
| Weighted Average Diluted Share | -- | -- | -- | $91.7M | $91.8M | |
| EBITDA | -- | -- | -- | -$86M | $71M | |
| EBIT | -- | -- | -- | -$86M | -$15M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -$2M | -$4M | |
| Operating Income (Adjusted) | -- | -- | -- | -$86M | -$15M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $13M | |
| Other Inc / (Exp) | -- | -- | -- | -$243M | $72M | |
| Operating Expenses | -- | -- | -- | -- | $13M | |
| Operating Income | -- | -- | -- | -- | -$13M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $30M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $7M | |
| Net Income to Company | -- | -- | -- | -- | $117M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $2M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $25M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.27 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.27 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | $145M | |
| EBIT | -- | -- | -- | -- | $59M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -$13M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $59M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $2M | $4M | |
| Other Inc / (Exp) | -- | -- | -- | -$84M | -$11M | |
| Operating Expenses | -- | -- | -- | $2M | $4M | |
| Operating Income | -- | -- | -- | -$2M | -$4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$93M | -$22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$20M | -$5M | |
| Net Income to Company | -- | -- | -- | -$73M | $77M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$73M | -$17M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.80 | -$0.19 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.80 | -$0.19 | |
| Weighted Average Basic Share | -- | -- | -- | $91.7M | $91.8M | |
| Weighted Average Diluted Share | -- | -- | -- | $91.7M | $91.8M | |
| EBITDA | -- | -- | -- | -$86M | $71M | |
| EBIT | -- | -- | -- | -$86M | -$15M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -$2M | -$4M | |
| Operating Income (Adjusted) | -- | -- | -- | -$86M | -$15M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $305M | $325M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $305M | $325M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | $333M | $458M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $357M | $223M | |
| Total Assets | -- | -- | -- | $1.2B | $1.2B | |
| Accounts Payable | -- | -- | -- | $2M | $3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $70M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | $8M | -- | |
| Total Current Liabilities | -- | -- | -- | $80M | $3M | |
| Long-Term Debt | -- | -- | -- | $1.2B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $1.3B | $1.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -$188M | -$359M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $23M | $22M | |
| Total Equity | -- | -- | -- | -$165M | -$337M | |
| Total Liabilities and Equity | -- | -- | -- | $1.2B | $1.2B | |
| Cash and Short Terms | -- | -- | -- | $305M | $325M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $298M | $314M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $298M | $315M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | $316M | $479M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $375M | $217M | |
| Total Assets | -- | -- | -- | $989M | $1.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | $19M | -- | |
| Total Current Liabilities | -- | -- | -- | $88M | -- | |
| Long-Term Debt | -- | -- | -- | $1.3B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $1.2B | $1.6B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $23M | $22M | |
| Total Equity | -- | -- | -- | -$259M | -$352M | |
| Total Liabilities and Equity | -- | -- | -- | $989M | $1.2B | |
| Cash and Short Terms | -- | -- | -- | $298M | $314M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$142M | -$33M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $2M | $4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$13M | -$14M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -$3M | -$3M | |
| Cash From Investing | -- | -- | -- | $1.1B | $105M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $1.1B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$918M | -$71M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $100M | -- | |
| Cash From Financing | -- | -- | -- | $317M | -$71M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $305M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $305M | $19M | |
| Ending Cash (CF) | -- | -- | -- | $305M | $325M | |
| Levered Free Cash Flow | -- | -- | -- | -$13M | -$14M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$73M | $77M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $86M | |
| Stock-Based Compensation | -- | -- | -- | $1M | $12M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$9M | $140M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$206M | |
| Cash From Investing | -- | -- | -- | -- | -$296M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $2M | -$1M | |
| Cash From Financing | -- | -- | -- | $2M | -$11M | |
| Beginning Cash (CF) | -- | -- | -- | $305M | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$7M | -$167M | |
| Ending Cash (CF) | -- | -- | -- | $298M | $1.2B | |
| Levered Free Cash Flow | -- | -- | -- | -$9M | $113M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $117M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $86M | |
| Stock-Based Compensation | -- | -- | -- | $1M | $15M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | $135M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$209M | |
| Cash From Investing | -- | -- | -- | -- | -$191M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$81M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$3M | |
| Cash From Financing | -- | -- | -- | -- | -$84M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$141M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $135M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$73M | $77M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $86M | |
| Stock-Based Compensation | -- | -- | -- | $1M | $12M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$9M | $140M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$206M | |
| Cash From Investing | -- | -- | -- | -- | -$296M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $2M | -$1M | |
| Cash From Financing | -- | -- | -- | $2M | -$11M | |
| Beginning Cash (CF) | -- | -- | -- | $305M | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$7M | -$167M | |
| Ending Cash (CF) | -- | -- | -- | $298M | $1.2B | |
| Levered Free Cash Flow | -- | -- | -- | -$9M | $113M | |
Get LLYVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LLYVA
Sector
P/E ratio
294.82x
17.70x
PEG ratio
--
0.00x
P/B ratio
--
1.49x
Price / LTM sales
--
0.96x
Growth Metrics
LLYVA
Sector
Revenue growth
--
-0.53%
Earnings growth
--
-0.61%
Revenue (5-year growth)
--
1.59%
Earnings forecast
--
$0.05
Profitability
LLYVA
Sector
Profitability FY 2024
--
$256.3M
Return on invested capital
--
0.79%
Return on assets
--
0.12%
Return on equity
--
2.1%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
LLYVA
Sector
Total cash
$314M
$97.1M
Short term investments
--
$26.8M
Total assets
$1.2B
$827.5M
Long term debt
--
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
